Global Histone H3K27 Methylation Levels are Different in Localized and Metastatic Prostate Cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Investigation

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/07357907.2011.636117PMID 22149091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma

  2012cited by this paper
• Global histone H4K20 trimethylation predicts cancer‐specific survival in patients with muscle‐invasive bladder cancer

  2011cited by this paper
• Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer

  2011cited by this paper
• Histone modifications and chromatin organization in prostate cancer.

  2010cited by this paper
• Global levels of histone modifications predict prostate cancer recurrence

  2010cited by this paper
• Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.

  2010cited by this paper
• An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

  2010cited by this paper
• Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy.

  2010cited by this paper
• Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma

  2010cited by this paper
• Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies.

  2010cited by this paper
• Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus

  2009cited by this paper
• The value of EZH2, p27kip1, BMI‐1 and MIB‐1 on biopsy specimens with low‐risk prostate cancer in selecting men with significant prostate cancer at prostatectomy

  2009cited by this paper
• Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.

  2009cited by this paper
• Global levels of histone modifications predict prognosis in different cancers.

  2009cited by this paper
• CpG Island hypermethylation in cell‐free serum DNA identifies patients with localized prostate cancer

  2008cited by this paper
• Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

  2008cited by this paper
• Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

  2008cited by this paper
• CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.

  2008cited by this paper
• Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

  2008cited by this paper
• A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.

  2007cited by this paper
• Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• Global histone modifications predict prognosis of resected non small-cell lung cancer.

  2007cited by this paper
• Global histone modification patterns predict risk of prostate cancer recurrence

  2005cited by this paper
• Chromosomal Instability and Tumors Promoted by DNA Hypomethylation

  2003cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test

  2025cites this paper
• Fueling Prostate Cancer: The Central Role of Glutamine/Glutamate Metabolic Reprogramming

  2025cites this paper
• Epigenetic regulation of MMP-11 and -16 expression in human prostate cancer: the role of KDM6A.

  2025cites this paper
• Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factors

  2023cites this paper
• Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer

  2022cites this paper
• Epigenetic reprogramming during prostate cancer progression: A perspective from development.

  2021cites this paper
• Testicular and prostate cancers

  2021cites this paper
• Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges

  2021cites this paper
• Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression

  2021cites this paper
• Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

  2021cites this paper
• Epigenetic Editing in Prostate Cancer: Challenges and Opportunities

  2021cites this paper
• Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention

  2020cites this paper
• Chromatin, histones, and histone modifications in health and disease

  2020cites this paper
• Computational prediction and analysis of histone H3k27me1-associated miRNAs.

  2020cites this paper
• Genomic Applications and Insights in Unravelling Cancer Signalling Pathways

  2019cites this paper
• Diagnostic utility of epigenetics in breast cancer - A review.

  2019cites this paper
• Analysis of H3K27me3 expression and DNA methylation at CCGG sites in smoking and non-smoking patients with non-small cell lung cancer and their clinical significance

  2018cites this paper
• Castration-Resistant Prostate Cancer

  2018cites this paper
• Curcumin Derivative Epigenetically Reactivates Nrf2 Antioxidative Stress Signaling in Mouse Prostate Cancer TRAMP C1 Cells.

  2018cites this paper
• Epigenetic regulation of prostate cancer: the theories and the clinical implications

  2018cites this paper
• SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer

  2017cites this paper
• Title High expression of trimethylated histone H 3 at lysine 27 predicts betterprognosis in non-small cell lung cancer

  2017cites this paper
• DNA and Histone Methylation in Prostate Cancer

  2017cites this paper
• Histone Methylation in Relation with Clinical Pathological Parameters in Prostate Cancer

  2017cites this paper
• The epigenetic basis of hematopoietic stem cell aging.

  2017cites this paper
• One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling

  2016cites this paper
• Epigenetic Significance of Chromatin Organization During Cellular Aging and Organismal Lifespan

  2016cites this paper
• A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma

  2016cites this paper
• Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell-Like Behaviors in Hepatocellular Carcinoma.

  2016cites this paper
• The Histone Code and Disease: Posttranslational Modifications as Potential Prognostic Factors for Clinical Diagnosis

  2016cites this paper
• Histone Posttranslational Modifications and Chromatin Remodelers in Prostate Cancer

  2016cites this paper
• Proteomic profiling identifies specific histone species associated with leukemic and cancer cells

  2015cites this paper
• Genomics and Epigenomics of Prostate Cancer

  2015cites this paper
• The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER‐positive breast cancers

  2015cites this paper
• The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

  2015influential citation
• Epigenetic alterations play a critical role in differentiation during development, and aberrations in epigenetic regulation are associated with tumorigenesis and cancer progression. Two types of epigenetic modifications, DNA methylation and the methylation of multiple histone lysines, play significa

  2014cites this paper
• Alterations of Global Histone H3K9 and H3K27 Methylation Levels in Bladder Cancer

  2014cites this paper
• Histone modifications, stem cells and prostate cancer.

  2014cites this paper
• Epigenetic biomarkers in prostate cancer: Current and future uses.

  2014cites this paper
• Prostate cancer epigenetic biomarkers: next-generation technologies

  2014cites this paper
• Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer

  2014cites this paper
• Evolution of H3K27me3-marked chromatin is linked to gene expression evolution and to patterns of gene duplication and diversification

  2014cites this paper
• Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes

  2014cites this paper
• Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma

  2013cites this paper
• Androgen Receptor-Regulated Genes in Prostate Cancer Initiation Versus Metastasis

  2013cites this paper
• Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target

  2013cites this paper
• Trithorax Genes in Prostate Cancer

  2013cites this paper
• Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

  2013cites this paper
• High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.

  2013cites this paper
• Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer.

  2013cites this paper
• Histone methylation defines an epigenetic entity in penile squamous cell carcinoma.

  2013cites this paper
• Histone modifications and cancer: biomarkers of prognosis?

  2012cites this paper
• Alterations of global histone H4K20 methylation during prostate carcinogenesis

  2012cites this paper